BRCA Mutation-Positive Ovarian Cancer Market

Key Players

  • The Vanguard Group
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb
  • Clovis Oncology
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • GSK
  • Merck KGaA
Future Market Insights

BRCA Mutation-Positive Ovarian Cancer Market